Loading...

Cochlear Limited

CHEOFPNK
Healthcare
Medical - Devices
$202.69
$0.00(0.00%)

Cochlear Limited (CHEOF) Financial Performance & Income Statement Overview

Review Cochlear Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
15.47%
15.47%
Operating Income Growth
26.45%
26.45%
Net Income Growth
18.70%
18.70%
Operating Cash Flow Growth
7.28%
7.28%
Operating Margin
21.70%
21.70%
Gross Margin
75.02%
75.02%
Net Profit Margin
15.85%
15.85%
ROE
19.70%
19.70%
ROIC
23.11%
23.11%

Cochlear Limited (CHEOF) Income Statement & Financial Overview

Review Cochlear Limited's (CHEOF) income statement with detailed quarterly and annual figures.

MetricQ4 2024Q2 2024
Net Income$165.40M$191.40M
Depreciation & Amortization$41.80M$43.10M
Deferred Income Tax$0.00$0.00
Stock Based Compensation$0.00$0.00
Change In Working Capital$9.40M-$84.00M
Accounts Receivables$0.00$0.00
Inventory$0.00$0.00
Accounts Payables$0.00$0.00
Other Working Capital$9.40M-$84.00M
Other Non-Cash Items$15.10M$92.80M
Net Cash From Operating Activities$231.70M$157.10M
Investments In Property Plant & Equipment-$47.10M-$42.70M
Acquisitions Net$0.00$0.00
Purchases Of Investments-$10.80M-$5.10M
Sales/Maturities Of Investments$0.00$0.00
Other Investing Activities$0.00-$25.20M
Net Cash Used For Investing Activities-$57.90M-$47.80M
Debt Repayment$0.00$0.00
Common Stock Issued$0.00$100000.00
Common Stock Repurchased-$300000.00-$45.50M
Dividends Paid-$131.00M-$114.70M
Other Financing Activities-$15.10M-$17.30M
Net Cash From Financing Activities-$146.40M-$177.40M
Effect Of Forex Changes On Cash$0.00-$2.20M
Net Change In Cash$28.40M-$70.30M
Cash At End Of Period$513.60M$485.20M
Cash At Beginning Of Period$485.20M$555.50M
Operating Cash Flow$231.70M$157.10M
Capital Expenditure-$47.10M-$42.70M
Free Cash Flow$184.60M$114.40M

Cochlear Limited (CHEOF) Cash Flow Analysis

$202.69
+0.00%

Cochlear Limited operates in the Healthcare sector as part of the Medical - Devices industry. The company is currently trading at $202.69 with a market capitalization of N/A.

Cash Flow Overview

Cash flow analysis provides insights into Cochlear Limited's financial health by examining how the company generates and uses cash. This analysis covers three main categories: operating activities, investing activities, and financing activities.

Key Cash Flow Metrics

Operating Cash Flow per Share (TTM)$5.92
Free Cash Flow per Share (TTM)$4.66
Cash per Share (TTM)$9.38
Free Cash Flow Yield (TTM)0.01%
Operating Cash Flow to Sales Ratio0.17

Financial Position Indicators

Current Ratio2.30
Working Capital$820.60M
Debt-to-Equity Ratio0.13
Price to Free Cash Flow66.94
Enterprise Value$20.20B

Stock Performance Summary

Cochlear Limited has shown the following performance over different time periods:

1-Day
+0.00%
5-Day
+0.57%
1-Month
-5.32%
YTD
-12.41%
52W Range
$148.62 - $237.38

Company Information

Headquarters: Sydney, AU

Employees: 4,996

Website:cochlear.com

Investment Metrics

P/E Ratio (TTM)57.89
EPS (TTM)$3.69
Dividend YieldN/A
Book Value per Share$28.01
ROE (TTM)19.70%

Understanding Cash Flow Statements

Cash flow statements are crucial financial documents that track the movement of cash in and out of a business. Unlike income statements that may include non-cash items, cash flow statements focus exclusively on actual cash transactions.

Three Components of Cash Flow:

Operating Activities

Cash generated from core business operations

Investing Activities

Cash used for investments in assets, acquisitions, or securities

Financing Activities

Cash from debt, equity financing, and dividend payments

Data Update: Financial data is updated regularly based on company filings. Last earnings announcement: August 15, 2025.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: USD. Exchange: PNK.

Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.

Cochlear Limited (CHEOF) Cash Flow Analysis

The cash flow statement reveals the Cochlear Limited (CHEOF) liquidity trends, with operating cash flow per share at $5.92, reflecting core business performance. Investing activity changes were 6.87%, indicating capital expenditures or asset sales, while financing activity shifted by 20.76%, showing debt or equity movements. Free cash flow per share was $4.66, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is 7.28%, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;